AR Signaling in Human Malignancies: Prostate Cancer and Beyond

signaling.jpg

Dublin Core

Title

AR Signaling in Human Malignancies: Prostate Cancer and Beyond

Subject

Cancer

Description

The notion that androgens and androgen receptor (AR) signaling are the hallmarks of prostate cancer oncogenesis and disease progression is generally well accepted. What is more poorly understood is the role of AR signaling in other human malignancies. This Special Issue of Cancers initially reviews the role of AR in advanced prostate cancer, and then explores the potential importance of AR signaling in other epithelial malignancies. The first few articles focus on the use of novel AR-targeting therapies in castration-resistant prostate cancer and the mechanisms of resistance to novel antiandrogens, and they also outline the interaction between AR and other cellular pathways, including PI3 kinase signaling, transcriptional regulation, angiogenesis, stromal factors, Wnt signaling, and epigenetic regulation in prostate cancer. The next several articles review the possible role of androgens and AR signaling in breast cancer, bladder cancer, salivary gland cancer, and hepatocellular carcinoma, as well as the potential treatment implications of using antiandrogen therapies in these non-prostatic malignancies.

Creator

Emmanuel S. Antonarakis (Ed.)

Source

https://directory.doabooks.org/handle/20.500.12854/41149

Publisher

www.mdpi.com/books

Date

2018

Contributor

Dewi Puspitasari

Rights

2018

Relation

Abd El-Rehim, D.M.; Ball, G.; Pinder, S.E.; Rakha, E.; Paish, C.; Robertson, J.F.; Macmillan, D.; Blamey, R.W.;
Ellis, I.O. High-throughput protein expression analysis using tissue microarray technology of a large
well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA
expression analyses. Int. J. Cancer 2005, 116, 340–350. [CrossRef] [PubMed]

Format

Pdf

Language

English

Type

Textbooks

Identifier

DOI
10.3390/books978-3-03842-739-1

Coverage

Basel

Document Viewer